代表性论文

1. Wang YY^#, Xiang BD^#, Ma L, Zhong JH, Ye JZ, Wang K, Xing BC^*, Li LQ^*. Development and Validation of a Nomogram to Preoperatively Estimate Post-hepatectomy Liver Dysfunction Risk and Long-term Survival in Patients With Hepatocellular Carcinoma. Ann Surg. 2020 Feb 24. 

2. Qi LN^#, Xiang BD^#, Wu FX^#, Ye JZ, Zhong JH, Wang YY, Chen YY, Chen ZS, Ma L, Chen J, Gong WF, Han ZG, Lu Y, Shang JJ, Li LQ^*. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. Cancer Res. 2018;78(16):4731-4744

3. Wei C^#, Yang X^#, Liu N^#, Geng J, Tai Y, Sun Z, Mei G, Zhou P, Peng Y, Wang C, Zhang X, Zhang P, Geng Y, Wang Y, Zhang X, Liu X, Zhang Y, Wu F^*, He X^*, Zhong H^*. Tumor Microenvironment Regulation by the Endoplasmic Reticulum Stress Transmission Mediator Golgi Protein 73 in Mice. Hepatology. 2019;70(3):851-870

4. Peng Z, Wang P, Song W, Yao Q, Li Y, Liu L, Li Y^*, Zhou S^*. GSDME enhances Cisplatin sensitivity to regress non-small cell lung carcinoma by mediating pyroptosis to trigger antitumor immunocyte infiltration. Signal Transduct Target Ther. 2020;5(1):159

5. Yang Z, Chen D, Zhang J, Yao D, Gao K, Wang H, Liu C, Yu J, Li L^*. The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study. Gynecol Oncol. 2016;141(2):231-239

6. Debelius JW, Huang T, Cai Y, Ploner A, Barrett D, Zhou X, Xiao X, Li Y, Liao J, Zheng Y, Huang G, Adami HO, Zeng Y, Zhang Z^*, Ye W. Subspecies Niche Specialization in the Oral Microbiome Is Associated with Nasopharyngeal Carcinoma Risk. mSystems. 2020;5(4):e00065-205(4)

7. Yin F^#, Shu L^#, Liu X^#, Li T, Peng T, Nan Y, Li S, Zeng X^*, Qiu X^*. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2016;35(1):127

8. 臧伟伟, 苏明华, 零小樟, 王荣明, 曹汴川, 吴育龙, 邓德丽, 韦慧兰, 梁先帅, 江建宁^*. 长期核苷(酸)类似物治疗的乙型肝炎肝硬化患者发生肝癌的危险因素[J]. 中华肝脏病杂志, 2020,28(08):679-685

 9. 吴育龙,苏明华,王荣明,曹汴川,李慧姣,王慧雯,零小樟,臧伟伟,江建宁^*. 慢性乙型肝炎患者乙型肝炎病毒DNA自发清除相关因素分析[J]. 中华传染病杂志,2018,36(07):401-404

10. 赵冰冰, 阳志军, 王琪，潘忠勉，张玮，李力^* . 多指标联合检测的液态悬浮芯片技术在卵巢恶性肿瘤诊断中的应用[J]. 中华妇产科杂志, 2017(1)  

11. Li Z^#, Peng B^#, Chen S, Li J, Hu K, Liao L, Xie Q, Yao M, Liang L, Tomlinson S, Yuan G^*, He S^*. Transcriptome sequencing and metabolome analysis reveal the metabolic reprogramming of partial hepatectomy and extended hepatectomy. BMC Genomics. 2023 Sep 7; 24(1):532.

12. Jiang K^#, Lu S^#, Li D, Liu M, Jin H, Lei B, Wang S, Long K, He S, Zhong F. Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization. J Gastroenterol. 2023 Sep; 58(9):894-907.

13. Zhao H, Wang Y, Yang Y. Follicular development and ovary aging: single-cell studies. Biol Reprod. 2023 Jul 28:ioad080.

14. Meng Z, Li P, Yang D, Huang H, Dong H, Qin Y, Bin Y, Li R, Wang S, Chen X, Kang M. The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline. Radiother Oncol. 2023 Nov 24; 191:110027.

15. Lin C^#, Lei B^#, Dong C^#, Chen J, Chen S, Jiang K, Zeng Y, Su H, Jin H, Qiu X, Li Z, Hu Z, Yu S, Zhang C, Lu S, Atkinson C, Tomlinson S, Zhong F^*, Yuan G^*, He S^*. Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling. Am J Transplant. 2023 Apr; 23(4):484-497.

16. Guo Z^#, Chen J^#, Zeng Y, Wang Z, Yao M, Tomlinson S, Chen B^*, Yuan G^*, He S^*. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice. Front Immunol. 2022 Jan 7; 12:785287.

17. Zheng C, Sleiman MM, Yang X, He S, Atkinson C, Tomlinson S. Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope. J Heart Lung Transplant. 2021 Oct; 40(10):1112-1121.

18. Lei B^#, Sleiman MM^#, Cheng Q, Tu Z, Zhu P, Goddard M, Martins PN, Langerude L, Nadig S, Tomlinson S^*, Atkinson C^*. In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries. Front Immunol. 2021 Jul 29; 12:630581.